# OnCo record rk-33 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/rk-33/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "rk-33" ;
  schema:name "RK-33"@en ;
  schema:description "RK-33 is an experimental drug from NATSAR Pharmaceuticals that blocks the DDX3 protein in cancer cells. It has been studied in the laboratory and a first trial in people is planned."@en ;
  schema:url <https://onco.cc/drugs/rk-33/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.natsarpharmaceuticals.com/>, <https://reporter.nih.gov/project-details/11419762> ;
  onco:status "preclinical" ;
  onco:tag "pipeline" ;
  onco:modality "Small-molecule inhibitor" ;
  onco:targets <https://onco.cc/targets/ddx3x/> ;
  onco:companies <https://onco.cc/companies/natsar-pharmaceuticals/> .